The observation of a reduction in the counts of circulating TN CD4+ lymphocytes in long-disease-duration and DMARD-treated patients has supported the knowledge of a deficient function of the thymus in RA patients [18,25]. The gene discussed is CD4; the disease is rheumatoid arthritis.